Zoria BiotechP.S.A.
Research and experimental development in natural sciences and engineering
Overview
Zoria Biotech develops chemical stabilization systems that keep biological assets viable during transport without refrigeration, dry ice, or power for civilian applications, field medicine, tactical logistics, and advanced research. The ZORIA T-37 System (TRL 4, patent application P.454716) preserves sample viability and antibiotic-resistance profiles for 72 hours at 37°C, with validation covering Gram-positive and Gram-negative pathogens under CLSI M40-A2.
Industry
Offer
- Chemical stabilization systems
- Biological material transport system
- Biological sample stabilization
- Medical logistics systems
Clients and partners
Website technology
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner |
|---|
Jakub Jan Mazurage 22 |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2026-05-01.
67 1020 4405 0000 2002 0724 3605
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Scope FluidicsS.A. | $4,660,220.99 | scopefluidics.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl |
FAQ
Last updated: 2026-04-08